Arkema (ENXTPA:AKE) Following Softer Half Year Earnings Still Looks Near Fair Value
Why Arkema’s Latest Half Year Earnings Matter For Investors
Arkema (ENXTPA:AKE) reported half year 2026 results with sales of €4,609.6 million and net income of €92.9 million, both lower than a year earlier. Earnings per share also declined over the period.
See our latest analysis for Arkema.
Arkema’s latest half year earnings came alongside a 1 month share price return of 8.04% and a year to date share price return of 16.81%, although the 3 year total shareholder return declined 26.02%. This suggests recent momentum has improved while longer term results remain weaker.
If Arkema’s recent move has you thinking about other opportunities, this is a good time to scan the market for established producers through the 8 top copper producer stocks
Arkema’s share price has picked up while the stock still sits at a sizeable modeled discount to an intrinsic estimate and only a small gap to analyst targets. Is that simply caution around softer earnings or an opportunity the market is leaving on the table?
Most Popular Narrative: 3.9% Undervalued
Arkema’s most followed narrative points to a fair value of €63.63 against a last close of €61.15, which frames the recent rebound in a different light and sets up a closer look at what is driving that gap.
The company's sustained emphasis on R&D and innovation (especially in differentiated materials for batteries, 3D printing, bio-based polymers, and advanced electronics) enhances Arkema's ability to introduce high-value, eco-friendly products that can command premium pricing, supporting long-term revenue growth and gross margin expansion.
Want to see what kind of revenue profile and margin reset needs to sit behind that fair value for Arkema? The narrative leans heavily on faster earnings growth, a richer product mix, and a lower future profit multiple than many investors might assume.
Result: Fair Value of €63.63 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors also need to keep an eye on weaker demand in key end markets and higher input costs, which could quickly challenge Arkema's upbeat valuation narrative.
Find out about the key risks to this Arkema narrative.
Next Steps
With Arkema presenting both pressure points and bright spots, it makes sense to look beyond headlines and study the underlying numbers yourself. If you want a structured view of what could go right and what might go wrong, take a closer look at the 3 key rewards and 3 important warning signs
Looking For More Investment Ideas Beyond Arkema?
If Arkema has sharpened your focus on quality opportunities, put that momentum to work and line up a few more stocks that deserve space on your watchlist.
- Spot potential turnaround stories by scanning 224 elite penny stocks with strong financials that already show stronger financial foundations than many investors expect.
- Target quality at sensible prices by using the 253 high quality undervalued stocks to search for companies with solid fundamentals that the market might be pricing cautiously.
- Strengthen your income ideas by reviewing the 441 dividend fortresses and focus on companies where higher yields come with robust financial backing.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com